We further screened for CDK6 expression by analyzing the Gene Expression Profiling Interactive Analysis (GEPIA) database and found that the aberrant expression of CDK6 was observed in AML patients among 33 types of human cancer (Figure 1C). This evidence concerns the gene CDK6 and cancer.